{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T00:51:20Z","timestamp":1789519880304,"version":"build-2803163510"},"reference-count":112,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,5,8]],"date-time":"2020-05-08T00:00:00Z","timestamp":1588896000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell. Infect. Microbiol."],"DOI":"10.3389\/fcimb.2020.00210","type":"journal-article","created":{"date-parts":[[2020,5,8]],"date-time":"2020-05-08T08:55:41Z","timestamp":1588928141000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":36,"title":["Precision Health for Chagas Disease: Integrating Parasite and Host Factors to Predict Outcome of Infection and Response to Therapy"],"prefix":"10.3389","volume":"10","author":[{"given":"Santiago J.","family":"Martinez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia S.","family":"Romano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David M.","family":"Engman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,5,8]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.exppara.2017.02.013","article-title":"Polymorphisms of blood forms and in vitro metacyclogenesis of Trypanosoma cruzi I, II, and IV","volume":"176","author":"Abegg","year":"2017","journal-title":"Exp. Parasitol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1080\/14787210.2017.1286979","article-title":"Long-term comparative pharmacovigilance of orally transmitted Chagas disease: first report","volume":"15","author":"Alarc\u00f3n de Noya","year":"2017","journal-title":"Exp. Rev. Anti. Infect. Ther."},{"key":"B3","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1093\/intimm\/dxh387","article-title":"Trypanosoma cruzi modulates the profile of memory CD8+ T cells in chronic Chagas' disease patients","volume":"18","author":"Albareda","year":"2006","journal-title":"Int. Immunol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1128\/AAC.00745-15","article-title":"New scheme of intermittent benznidazole administration in patients chronically infected with Trypanosoma cruzi: a pilot short-term follow-up study with adult patients","volume":"60","author":"\u00c1lvarez","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"key":"B5","doi-asserted-by":"publisher","first-page":"243","DOI":"10.2147\/DDDT.S8338","article-title":"Current and developing therapeutic agents in the treatment of Chagas disease","volume":"4","author":"Apt","year":"2010","journal-title":"Drug Des. Devel. Ther."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1111\/cmi.12119","article-title":"Trypanosoma cruzi highjacks TrkC to enter cardiomyocytes and cardiac fibroblasts while exploiting TrkA for cardioprotection against oxidative stress","volume":"15","author":"Aridgides","year":"2013","journal-title":"Cell. Microbiol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"e1870","DOI":"10.1371\/journal.pntd.0001870","article-title":"Fexinidazole: a potential new drug candidate for chagas disease","volume":"6","author":"Bahia","year":"2012","journal-title":"PLoS Negl. Trop. Dis."},{"key":"B8","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.actatropica.2017.05.003","article-title":"Identification of novel mammalian hosts and Brazilian biome geographic distribution of Trypanosoma cruzi TcIII and TcIV","volume":"172","author":"Barros","year":"2017","journal-title":"Acta Trop."},{"key":"B9","doi-asserted-by":"publisher","first-page":"e711","DOI":"10.1371\/journal.pntd.0000711","article-title":"Clinical outcomes of thirteen patients with acute chagas disease acquired through oral transmission from two urban outbreaks in Northeastern Brazil","volume":"4","author":"Bastos","year":"2010","journal-title":"PLoS Negl. Trop. Dis."},{"key":"B10","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1016\/j.ejmech.2015.01.065","article-title":"Computer-guided drug repurposing: identification of trypanocidal activity of clofazimine, benidipine and saquinavir","volume":"93","author":"Bellera","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"B11","doi-asserted-by":"publisher","first-page":"3720","DOI":"10.1128\/AAC.00207-12","article-title":"In vitro anti-Trypanosoma cruzi activity of dronedarone, a novel amiodarone derivative with an improved safety profile","volume":"56","author":"Benaim","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"key":"B12","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1038\/nrcardio.2012.108","article-title":"The emerging role of amiodarone and dronedarone in Chagas disease","volume":"9","author":"Benaim","year":"2012","journal-title":"Nat. Rev. Cardiol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"2171","DOI":"10.1001\/jama.298.18.2171","article-title":"Evaluation and treatment of chagas disease in the United States: a systematic review","volume":"298","author":"Bern","year":"2007","journal-title":"J. Am. Med. Assoc."},{"key":"B14","doi-asserted-by":"publisher","first-page":"FSO422","DOI":"10.2144\/fsoa-2019-0103","article-title":"Trypanosoma cruzi lineage-specific serology: New rapid tests for resolving clinical and ecological associations","volume":"5","author":"Bhattacharyya","year":"2019","journal-title":"Futur. Sci. OA"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1510","DOI":"10.1016\/j.jacc.2017.08.004","article-title":"Chronic chagas heart disease management: from etiology to cardiomyopathy treatment","volume":"70","author":"Bocchi","year":"2017","journal-title":"J. Am. Coll. Cardiol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.1016\/j.ajpath.2014.12.023","article-title":"Autoimmune pathogenesis of Chagas heart disease: looking back, looking ahead","volume":"185","author":"Bonney","year":"2015","journal-title":"Am. J. Pathol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1146\/annurev-pathol-020117-043711","article-title":"Pathology and pathogenesis of chagas heart disease","volume":"14","author":"Bonney","year":"2019","journal-title":"Annu. Rev. Pathol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"e0004792","DOI":"10.1371\/journal.pntd.0004792","article-title":"Over six thousand Trypanosoma cruzi strains classified into discrete typing units (DTUs): attempt at an Inventory","volume":"10","author":"Breni\u00e8re","year":"2016","journal-title":"PLoS Negl. Trop. Dis."},{"key":"B19","first-page":"176","article-title":"Polymerase chain reaction (PCR) as a laboratory tool for the evaluation of the parasitological cure in chagas disease after specific treatment","volume":"59","author":"Britto","year":"1999","journal-title":"Medicina."},{"key":"B20","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1093\/infdis\/jit420","article-title":"New, combined, and reduced dosing treatment protocols cure trypanosoma cruzi infection in mice","volume":"209","author":"Bustamante","year":"2014","journal-title":"J. Infect. Dis."},{"key":"B21","doi-asserted-by":"publisher","first-page":"ftv082","DOI":"10.1093\/femspd\/ftv082","article-title":"Immunity and immune modulation in Trypanosoma cruzi infection","volume":"73","author":"Cardillo","year":"2015","journal-title":"Pathog. Dis."},{"key":"B22","doi-asserted-by":"publisher","first-page":"e0006814","DOI":"10.1371\/journal.pntd.0006814","article-title":"Beneficial effects of benznidazole in Chagas disease: NIH SaMi-Trop cohort study","volume":"12","author":"Cardoso","year":"2018","journal-title":"PLoS Negl. Trop. Dis."},{"key":"B23","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1080\/21505594.2019.1584027","article-title":"Autophagy plays a protective role against Trypanosoma cruzi infection in mice","volume":"10","author":"Casassa","year":"2019","journal-title":"Virulence"},{"key":"B24","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1191\/0960327106het653oa","article-title":"Toxic side effects of drugs used to treat Chagas' disease (American Trypanosomiasis)","volume":"25","author":"Castro","year":"2006","journal-title":"Hum. Exp. Toxicol."},{"key":"B25","first-page":"19","article-title":"Toxic effects of nifurtimox and benznidazole, two drugs used against American trypanosomiasis (Chagas' disease)","volume":"1","author":"Castro","year":"1988","journal-title":"Biomed. Environ. Sci."},{"key":"B26","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1016\/j.ijantimicag.2012.08.002","article-title":"Evaluation of benznidazole treatment combined with nifurtimox, posaconazole or AmBisome\u00ae in mice infected with Trypanosoma cruzi strains","volume":"40","author":"Cencig","year":"2012","journal-title":"Int. J. Antimicrob. Agents"},{"key":"B27","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1590\/S0074-02761909000200008","article-title":"Nova trypanosom\u00edase humana. Estudo sobre a morfologia e o ciclo evolutivo do Schizotripanum cruzi n. gen. Sp, ajente etiol\u00f3jico de nova entidade m\u00f3rbida do homem","volume":"1","author":"Chagas","year":"1909","journal-title":"Mem. Inst. Oswaldo Cruz"},{"key":"B28","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1016\/S0020-7519(02)00028-0","article-title":"Significance of inducible nitric oxide synthase in acute myocarditis caused by Trypanosoma cruzi (Tulahuen strain)","volume":"32","author":"Chandra","year":"2002","journal-title":"Int. J. Parasitol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1590\/0074-0276140362","article-title":"The main sceneries of Chagas disease transmission. The vectors, blood and oral transmissions - A comprehensive review","volume":"110","author":"Coura","year":"2014","journal-title":"Mem. Inst. Oswaldo Cruz"},{"key":"B30","doi-asserted-by":"publisher","first-page":"1344.e1","DOI":"10.1016\/j.cmi.2018.06.006","article-title":"Toxicity of nifurtimox as second-line treatment after benznidazole intolerance in patients with chronic Chagas disease: when available options fail","volume":"24","author":"Crespillo-And\u00fajar","year":"2018","journal-title":"Clin. Microbiol. Infect."},{"key":"B31","doi-asserted-by":"publisher","first-page":"1842","DOI":"10.3389\/fimmu.2018.01842","article-title":"Autoimmunity in chronic chagas disease: a road of multiple pathways to cardiomyopathy?","volume":"9","author":"De Bona","year":"2018","journal-title":"Front. Immunol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1007\/s00436-007-0829-8","article-title":"Applicability of the use of charcoal for the evaluation of intestinal motility in a murine model of Trypanosoma cruzi infection","volume":"102","author":"De Oliveira","year":"2008","journal-title":"Parasitol. Res."},{"key":"B33","doi-asserted-by":"publisher","first-page":"e79629","DOI":"10.1371\/journal.pone.0079629","article-title":"Genome wide association study (GWAS) of chagas cardiomyopathy in trypanosoma cruzi seropositive subjects","volume":"8","author":"Deng","year":"2013","journal-title":"PLoS ONE"},{"key":"B34","unstructured":"The BENDITA Study: A Phase II Study to Assess Safety, Tolerability, and Efficacy of Different Benznidazole Regimens, Alone and in Combination with Fosravuconazole2019"},{"key":"B35","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.4269\/ajtmh.16-0455","article-title":"A case of cardboard boxes likely facilitating the biting of a patient by Trypanosoma cruzi-infected Triatomine bugs","volume":"95","author":"Dolhun","year":"2016","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"B36","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1016\/j.pt.2020.01.008","article-title":"Next-generation molecular surveillance of TriTryp diseases","volume":"36","author":"Domagalska","year":"2020","journal-title":"Trends Parasitol"},{"key":"B37","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1093\/intimm\/6.4.499","article-title":"Activated T and B lymphocytes in peripheral blood of patients with Chagas' disease","volume":"6","author":"Dutra","year":"1994","journal-title":"Int. Immunol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1046\/j.1365-3083.1996.d01-9.x","article-title":"Chagasic patients lack CD28 expression on many of their circulating T lymphocytes","volume":"43","author":"Dutra","year":"1996","journal-title":"Scand. J. Immunol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"e01427","DOI":"10.1128\/mBio.01427-17","article-title":"Cell cycle inhibition to treat sleeping sickness","volume":"8","author":"Epting","year":"2017","journal-title":"MBio"},{"key":"B40","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1038\/nature21056","article-title":"Dermatologist-level classification of skin cancer with deep neural networks","volume":"542","author":"Esteva","year":"2017","journal-title":"Nature"},{"key":"B41","doi-asserted-by":"publisher","first-page":"553","DOI":"10.3389\/fmicb.2018.00553","article-title":"BALB\/c and C57BL\/6 mice cytokine responses to Trypanosoma cruzi infection are independent of parasite strain infectivity","volume":"9","author":"Ferreira","year":"2018","journal-title":"Front. Microbiol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1590\/S0074-02761984000200008","article-title":"A rapid method for testing in vivo the susceptibility of different strains of Trypanosoma cruzi to active chemotherapeutic agents","volume":"79","author":"Filardi","year":"1984","journal-title":"Mem. Inst. Oswaldo Cruz"},{"key":"B43","doi-asserted-by":"publisher","first-page":"e0004508","DOI":"10.1371\/journal.pntd.0004508","article-title":"Evaluation of parasiticide treatment with benznidazol in the electrocardiographic, clinical, and serological evolution of Chagas disease","volume":"10","author":"Fragata-Filho","year":"2016","journal-title":"PLoS Negl. Trop. Dis."},{"key":"B44","doi-asserted-by":"publisher","first-page":"4653","DOI":"10.1128\/AAC.00520-15","article-title":"Limited ability of posaconazole to cure both acute and chronic Trypanosoma cruzi infections revealed by highly sensitive in vivo imaging","volume":"59","author":"Francisco","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"B45","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.ejps.2018.04.034","article-title":"Multi-kinetic release of benznidazole-loaded multiparticulate drug delivery systems based on polymethacrylate interpolyelectrolyte complexes","volume":"120","author":"Garc\u00eda","year":"2018","journal-title":"Eur. J. Pharm. Sci."},{"key":"B46","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1038\/s41598-018-37638-9","article-title":"Convolutional neural networks can accurately distinguish four histologic growth patterns of lung adenocarcinoma in digital slides","volume":"9","author":"Gertych","year":"2019","journal-title":"Sci. Rep."},{"key":"B47","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1016\/j.micinf.2004.07.010","article-title":"Immune response to a major Trypanosoma cruzi antigen, cruzipain, is differentially modulated in C57BL\/6 and BALB\/c mice","volume":"6","author":"Gui\u00f1az\u00fa","year":"2004","journal-title":"Microbes Infect."},{"key":"B48","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1146\/annurev-micro-090816-093813","article-title":"Evolutionary trajectories to antibiotic resistance","volume":"71","author":"Hughes","year":"2017","journal-title":"Annu. Rev. Microbiol."},{"key":"B49","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1016\/j.ijpara.2008.04.002","article-title":"Bioluminescent imaging of Trypanosoma cruzi infection","volume":"38","author":"Hyland","year":"2008","journal-title":"Int. J. Parasitol."},{"key":"B50","doi-asserted-by":"publisher","first-page":"3641","DOI":"10.1128\/IAI.00423-07","article-title":"Modulation of autoimmunity by treatment of an infectious disease","volume":"75","author":"Hyland","year":"2007","journal-title":"Infect Immun"},{"key":"B51","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1007\/BF00925477","article-title":"The interaction of myotropic and macrophagotropic strains of Trypanosoma cruzi with myoblasts and fibers of skeletal muscle","volume":"72","author":"Jorge","year":"1986","journal-title":"Zeitschrift f\u00fcr Parasitenkd. Parasitol. Res."},{"key":"B52","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.4269\/ajtmh.19-0050","article-title":"Leveraging technology to manage Chagas disease by tracking domestic and sylvatic animal hosts as sentinels: a systematic review","volume":"101","author":"Kruse","year":"2019","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"B53","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1111\/cmi.12297","article-title":"Bioluminescence imaging of chronic Trypanosoma cruzi infections reveals tissue-specific parasite dynamics and heart disease in the absence of locally persistent infection","volume":"16","author":"Lewis","year":"2014","journal-title":"Cell. Microbiol."},{"key":"B54","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.actatropica.2015.07.015","article-title":"Genetic diversity of Trypanosoma cruzi in bats, and multilocus phylogenetic and phylogeographical analyses supporting Tcbat as an independent DTU (discrete typing unit)","volume":"151","author":"Lima","year":"2015","journal-title":"Acta Trop."},{"key":"B55","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.1017\/S0031182012000856","article-title":"Direct molecular identification of Trypanosoma cruzi discrete typing units in domestic and peridomestic triatoma infestans and triatoma sordida from the argentine Chaco","volume":"139","author":"Maffey","year":"2012","journal-title":"Parasitology"},{"key":"B56","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.actatropica.2018.07.001","article-title":"Differential infectivity of two Trypanosoma cruzi strains in placental cells and tissue","volume":"186","author":"Medina","year":"2018","journal-title":"Acta Trop."},{"key":"B57","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1111\/j.1365-2249.2004.02479.x","article-title":"Phenotypic and functional characteristics of CD28+ and CD28- cells from chagasic patients: distinct repertoire and cytokine expression","volume":"137","author":"Menezes","year":"2004","journal-title":"Clin. Exp. Immunol."},{"key":"B58","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1586\/14787210.2015.1056158","article-title":"Between a bug and a hard place: Trypanosoma cruzi genetic diversity and the clinical outcomes of Chagas disease","volume":"13","author":"Messenger","year":"2015","journal-title":"Expert Rev. Anti. Infect. Ther."},{"key":"B59","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1007\/s40506-018-0170-z","article-title":"Treatment of Chagas disease in the United States","volume":"10","author":"Meymandi","year":"2018","journal-title":"Curr. Treat. Options Infect. Dis."},{"key":"B60","unstructured":"MeymandiS. K.\n          Center of Excellence for Chagas Disease2020"},{"key":"B61","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1093\/cid\/cix064","article-title":"Prevalence of Chagas disease in the latin american-born population of Los Angeles","volume":"64","author":"Meymandi","year":"2017","journal-title":"Clin. Infect. Dis."},{"key":"B62","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1016\/S0002-9440(10)63019-2","article-title":"Pivotal role of interleukin-12 and interferon-\u03b3 axis in controlling tissue parasitism and inflammation in the heart and central nervous system during Trypanosoma cruzi infection","volume":"159","author":"Michailowsky","year":"2001","journal-title":"Am. J. Pathol."},{"key":"B63","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1111\/j.1365-2249.1997.267-ce1166.x","article-title":"Different Trypanosoma cruzi strains promote neuromyopathic damage mediated by distinct T lymphocyte subsets","volume":"107","author":"Mirkin","year":"1997","journal-title":"Clin. Exp. Immunol."},{"key":"B64","doi-asserted-by":"publisher","first-page":"1899","DOI":"10.1056\/NEJMoa1313122","article-title":"Randomized trial of posaconazole and benznidazole for chronic Chagas' disease","volume":"370","author":"Molina","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"B65","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1590\/S0074-02762003000500001","article-title":"Chagas disease: current epidemiological trends after the interruption of vectorial and transfusional transmission in the Southern Cone countries","volume":"98","author":"Moncayo","year":"2003","journal-title":"Mem. Inst. Oswaldo Cruz"},{"key":"B66","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.4269\/ajtmh.16-0213","article-title":"What do we know about chagas disease in the United States?","volume":"95","author":"Montgomery","year":"2016","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"B67","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.ijpharm.2004.03.025","article-title":"Intravenous liposomal benznidazole as trypanocidal agent: increasing drug delivery to liver is not enough","volume":"278","author":"Morilla","year":"2004","journal-title":"Int. J. Pharm."},{"key":"B68","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1056\/NEJMoa1507574","article-title":"Randomized trial of benznidazole for chronic chagas' cardiomyopathy","volume":"373","author":"Morillo","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"B69","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1016\/j.jacc.2016.12.023","article-title":"Benznidazole and posaconazole in eliminating parasites in asymptomatic T. cruzi carriers","volume":"69","author":"Morillo","year":"2017","journal-title":"J. Am. Coll. Cardiol."},{"key":"B70","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1016\/j.jacc.2013.05.046","article-title":"Chagas disease: an overview of clinical and epidemiological aspects","volume":"62","author":"Nunes","year":"2013","journal-title":"J. Am. Coll. Cardiol."},{"key":"B71","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1111\/pim.12341","article-title":"Proteomic profile of circulating immune complexes in chronic Chagas disease","volume":"38","author":"Ohyama","year":"2016","journal-title":"Parasite Immunol."},{"key":"B72","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.actatropica.2016.11.033","article-title":"TcI, TcII and TcVI Trypanosoma cruzi samples from Chagas disease patients with distinct clinical forms and critical analysis of in vitro and in vivo behavior, response to treatment and infection evolution in murine model","volume":"167","author":"Oliveira","year":"2017","journal-title":"Acta Trop."},{"key":"B73","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1590\/0037-8682-0399-2016","article-title":"Therapeutic drug monitoring of benznidazole and nifurtimox: a systematic review and quality assessment of published clinical practice guidelines","volume":"50","author":"Olivera","year":"2017","journal-title":"Rev. Soc. Bras. Med. Trop."},{"key":"B74","doi-asserted-by":"publisher","first-page":"e1006928","DOI":"10.1371\/journal.ppat.1006928","article-title":"ROS and Trypanosoma cruzi: Fuel to infection, poison to the heart","volume":"14","author":"Paiva","year":"2018","journal-title":"PLoS Pathog."},{"key":"B75","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1016\/S1473-3099(15)00243-1","article-title":"Old and new challenges in Chagas disease","volume":"15","author":"P\u00e9rez-Molina","year":"2015","journal-title":"Lancet Infect. Dis."},{"key":"B76","doi-asserted-by":"publisher","first-page":"e02410","DOI":"10.1128\/AAC.02410-16","article-title":"Pharmacokinetics and tissue distribution of benznidazole after oral administration in mice","volume":"61","author":"Perin","year":"2017","journal-title":"Antimicrob. Agents Chemother."},{"key":"B77","doi-asserted-by":"publisher","first-page":"e1965","DOI":"10.1371\/journal.pntd.0001965","article-title":"Immunosuppression and Chagas disease: a management challenge","volume":"7","author":"Pinazo","year":"2013","journal-title":"PLoS Negl. Trop. Dis."},{"key":"B78","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/0166-6851(82)90066-4","article-title":"Changes in morphology and infectivity of cell culture-derived trypomastigotes of Trypanosoma cruzi","volume":"6","author":"Piras","year":"1982","journal-title":"Mol. Biochem. Parasitol."},{"key":"B79","doi-asserted-by":"publisher","first-page":"S1684","DOI":"10.1016\/j.jmii.2018.12.004","article-title":"Deep sequencing reveals multiclonality and new discrete typing units of Trypanosoma cruzi in rodents from the southern United States","volume":"21","author":"Pronovost","year":"2018","journal-title":"J. Microbiol. Immunol. Infect"},{"key":"B80","doi-asserted-by":"publisher","first-page":"e0203462","DOI":"10.1371\/journal.pone.0203462","article-title":"Phenotypic diversity and drug susceptibility of Trypanosoma cruzi TcV clinical isolates","volume":"13","author":"Quebrada Palacio","year":"2018","journal-title":"PLoS ONE"},{"key":"B81","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1056\/NEJMra1814259","article-title":"Machine learning in medicine","volume":"380","author":"Rajkomar","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"B82","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1590\/0074-02760160334","article-title":"Chronic Chagas cardiomyopathy: a review of the main pathogenic mechanisms and the efficacy of aetiological treatment following the BENznidazole Evaluation for Interrupting Trypanosomiasis (BENEFIT) trial","volume":"112","author":"Rassi","year":"2017","journal-title":"Mem. Inst. Oswaldo Cruz"},{"key":"B83","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.ijcard.2009.04.034","article-title":"Predicting prognosis in patients with Chagas disease: why are the results of various studies so different?","volume":"145","author":"Rassi","year":"2010","journal-title":"Int. J. Cardiol."},{"key":"B84","doi-asserted-by":"publisher","first-page":"e01947","DOI":"10.1016\/j.heliyon.2019.e01947","article-title":"Repurposing of terconazole as an anti Trypanosoma cruzi agent","volume":"5","author":"Reigada","year":"2019","journal-title":"Heliyon"},{"key":"B85","doi-asserted-by":"publisher","first-page":"197","DOI":"10.3390\/pathogens8040197","article-title":"In vitro benznidazole and nifurtimox susceptibility profile of trypanosoma cruzi strains belonging to discrete typing units tci, tcii, and tcv","volume":"8","author":"Revollo","year":"2019","journal-title":"Pathogens"},{"key":"B86","author":"Riarte","year":"2012","journal-title":"Estudio TRAENA: Evaluaci\u00f3n de potenciales biomarcadores de eficacia terap\u00e9utica informativo N\u00b02"},{"key":"B87","doi-asserted-by":"publisher","first-page":"e0006939","DOI":"10.1371\/journal.pntd.0006939","article-title":"Exploring the parasite load and molecular diversity of Trypanosoma cruzi in patients with chronic Chagas disease from different regions of Brazil","volume":"12","author":"Rodrigues-dos-Santos","year":"2018","journal-title":"PLoS Negl. Trop. Dis."},{"key":"B88","doi-asserted-by":"publisher","first-page":"489758","DOI":"10.1155\/2015\/489758","article-title":"Experimental vaccines against chagas disease: a journey through history","volume":"2015","author":"Rodr\u00edguez-Morales","year":"2015","journal-title":"J. Immunol. Res."},{"key":"B89","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.4269\/ajtmh.16-0761","article-title":"Experimental and clinical treatment of chagas disease: a review","volume":"97","author":"Sales Junior","year":"2017","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"B90","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1515\/ap-2015-0060","article-title":"Trypanosoma cruzi DTU TcII presents higher blood parasitism than DTU TcI in an experimental model of mixed infection","volume":"60","author":"Sales-Campos","year":"2015","journal-title":"Acta Parasitol."},{"key":"B91","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.micinf.2016.08.003","article-title":"Decreased cruzipain and gp85\/trans-sialidase family protein expression contributes to loss of Trypanosoma cruzi trypomastigote virulence","volume":"19","author":"San Francisco","year":"2017","journal-title":"Microbes Infect."},{"key":"B92","doi-asserted-by":"publisher","first-page":"e34039","DOI":"10.7554\/eLife.34039","article-title":"Spontaneous dormancy protects trypanosoma cruzi during extended drug exposure","volume":"7","author":"S\u00e1nchez-Vald\u00e9z","year":"2018","journal-title":"Elife"},{"key":"B93","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1186\/1756-3305-7-267","article-title":"Trypanosoma cruzi strain TcI is associated with chronic Chagas disease in the Brazilian Amazon","volume":"7","author":"Santana","year":"2014","journal-title":"Parasit. Vectors"},{"key":"B94","doi-asserted-by":"publisher","first-page":"8893","DOI":"10.1038\/s41598-017-08086-8","article-title":"A multi-parametric analysis of Trypanosoma cruzi infection: common pathophysiologic patterns beyond extreme heterogeneity of host responses","volume":"7","author":"Santi-Rocca","year":"2017","journal-title":"Sci. Rep."},{"key":"B95","doi-asserted-by":"publisher","first-page":"388","DOI":"10.4269\/ajtmh.15-0889","article-title":"Promising efficacy of benznidazole nanoparticles in acute Trypanosoma cruzi murine model: in-vitro and in-vivo studies","volume":"95","author":"Scalise","year":"2016","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"B96","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/978-3-642-21396-0_9","article-title":"Interactions of Trypanosoma cruzi and Triatomines","volume-title":"Progress in Parasitology","author":"Schaub","year":"2011"},{"key":"B97","doi-asserted-by":"publisher","first-page":"e931","DOI":"10.1371\/journal.pntd.0000931","article-title":"International study to evaluate PCR methods for detection of Trypanosoma cruzi DNA in blood samples from Chagas disease patients","volume":"5","author":"Schijman","year":"2011","journal-title":"PLoS Negl. Trop. Dis."},{"key":"B98","doi-asserted-by":"publisher","first-page":"1886","DOI":"10.1128\/IAI.01931-06","article-title":"Trypanosoma cruzi infection induces differential modulation of costimulatory molecules and cytokines by monocytes and T cells from patients with indeterminate and cardiac Chagas' disease","volume":"75","author":"Souza","year":"2007","journal-title":"Infect. Immun."},{"key":"B99","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1186\/1756-3305-7-317","article-title":"The history of Chagas disease","volume":"7","author":"Steverding","year":"2014","journal-title":"Parasit Vect."},{"key":"B100","doi-asserted-by":"publisher","first-page":"105120","DOI":"10.1016\/j.actatropica.2019.105120","article-title":"Role of nucleic acid amplification assays in monitoring treatment response in chagas disease: usefulness in clinical trials","volume":"199","author":"Sulleiro","year":"2019","journal-title":"Acta Trop."},{"key":"B101","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1111\/tmi.12014","article-title":"In vivo susceptibility to benznidazole of Trypanosoma cruzi strains from the western Brazilian Amazon","volume":"18","author":"Teston","year":"2013","journal-title":"Trop. Med. Int. Heal."},{"key":"B102","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/S1473-3099(17)30538-8","article-title":"Treatment of adult chronic indeterminate Chagas disease with benznidazole and three E1224 dosing regimens: a proof-of-concept, randomised, placebo-controlled trial","volume":"18","author":"Torrico","year":"2018","journal-title":"Lancet Infect. Dis."},{"key":"B103","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.bjid.2018.02.009","article-title":"Trypanosoma cruzi: analysis of two different strains after piplartine treatment","volume":"22","author":"Vieira","year":"2018","journal-title":"Braz. J. Infect. Dis."},{"key":"B104","doi-asserted-by":"publisher","first-page":"CD003463","DOI":"10.1002\/14651858.CD003463.pub2","article-title":"Trypanocidal drugs for chronic asymptomatic Trypanosoma cruzi infection","volume":"27","author":"Villar","year":"2014","journal-title":"Cochrane Database Syst. Rev."},{"key":"B105","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1586\/14787210.7.2.157","article-title":"Side effects of benznidazole as treatment in chronic Chagas disease: fears and realities","volume":"7","author":"Viotti","year":"2009","journal-title":"Expert Rev. Anti. Infect. Ther."},{"key":"B106","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1056\/NEJMra1010600","article-title":"Genomics and drug response","volume":"364","author":"Wang","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"B107","unstructured":"Chagas disease (2020"},{"key":"B108","doi-asserted-by":"publisher","first-page":"eaar7939","DOI":"10.1126\/scitranslmed.aar7939","article-title":"A machine learning approach for somatic mutation discovery","volume":"10","author":"Wood","year":"2018","journal-title":"Sci. Transl. Med."},{"key":"B109","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/s41525-020-0120-9","article-title":"Whole slide images reflect DNA methylation patterns of human tumors","volume":"5","author":"Zheng","year":"2020","journal-title":"NPJ Genomic Med"},{"key":"B110","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.actatropica.2017.09.017","article-title":"Trypanosoma cruzi genetic diversity: something new for something known about Chagas disease manifestations, serodiagnosis and drug sensitivity","volume":"184","author":"Zingales","year":"2018","journal-title":"Acta Trop."},{"key":"B111","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1590\/S0074-02762009000700021","article-title":"A new consensus for Trypanosoma cruzi intraspecific nomenclature: second revision meeting recommends TcI to TcVI","volume":"104","author":"Zingales","year":"2009","journal-title":"Mem. Inst. Oswaldo Cruz"},{"key":"B112","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1111\/j.1365-3156.1997.tb00171.x","article-title":"Protective effect of Trypanosoma rangeli against infections with a highly virulent strain of Trypanosoma cruzi","volume":"2","author":"Zu\u00f1iga","year":"1997","journal-title":"Trop. Med. Int. Heal."}],"container-title":["Frontiers in Cellular and Infection Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fcimb.2020.00210\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,8]],"date-time":"2020-05-08T08:55:46Z","timestamp":1588928146000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fcimb.2020.00210\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,8]]},"references-count":112,"alternative-id":["10.3389\/fcimb.2020.00210"],"URL":"https:\/\/doi.org\/10.3389\/fcimb.2020.00210","relation":{},"ISSN":["2235-2988"],"issn-type":[{"value":"2235-2988","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,8]]},"article-number":"210"}}